In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

DexCom, Inc.

http://www.dexcom.com

Latest From DexCom, Inc.

Dexcom Touts G7 As ‘The Most Accurate CGM’ As It Prepares For US Launch

The US FDA has granted authorization to Dexcom to market its G7 continuous glucose monitor, which the company will launch in the next couple of months.

Diabetic Care Approvals

Tandem’s CSO Speaks On Insulin Pump Development And Its Challenges

Insulin pumps have lagged behind continuous glucose monitors in terms of market penetration due to their cost and the complex regulatory framework that surrounds them. Elizabeth Gasser, chief strategy officer at Tandem Diabetes spoke to Medtech Insight about these challenges and how the company is taking a slightly different approach to pumps.

Strategy Platform Technologies

Bigfoot Looks To Unlock More Effective Treatments For Type II Diabetics

Bigfoot Biomedical’s Unity system pairs continuous glucose monitoring with smart insulin pen caps, giving patients recommendations on insulin dosing. Because patient interaction is involved, Bigfoot Biomedical can deliver insulin pump-like results to pump-ineligible type II diabetics.

Diabetic Care Platform Technologies

Digital Health Roundup: Telehealth Strong, Diabetes Recalls And Expansions, AI And Radiology

In this month’s Digital Health Roundup, Medtech Insight’s Reed Miller offers a recap from the recent TCT 2022 meeting and talks about Butterfly Network’s expansion into Africa while Marion Webb highlights her interview with Aidoc’s CEO Elad Walach discussing plans for the AI-based software company.

Digital Health Artificial Intelligence
See All

Company Information

  • Industry
  • Medical Devices
    • Monitoring Equipment & Devices
  • In Vitro Diagnostics
    • Biosensors
    • Glucose Testing
  • Other Names / Subsidiaries
    • SweetSpot Diabetes Care
    • TypeZero Technologies, LLC
UsernamePublicRestriction

Register